x
  
  

Welcome To TAMIU Student Health

If you are a registered student in need of an appointment, call 956-326-2235.  You can also contact us at studenthealth@tamiu.edu 

Hours of Operation

Monday and Tuesday:   8 a.m. - 5 p.m. 

Wednesday and Thursday:  8 a.m. - 6 p.m.

Friday:  8am - 3pm 

Closed Daily for Lunch: 12 p.m. - 1 p.m.

Closed on Saturday and Sunday

 

COVID-19 reporting information 

If you are an enrolled student for the current semester and you have tested positive for COVID-19, you must report your case to the Office of Student Health Services.  You can reach us at 956-326-2235.

 

covidhorizontal2023


COVID-19 Testing

Rapid Antigen Testing Schedule
(Available ONLY to TAMIU Community)

Rapid Antigen Testing Schedule
Day Time Location
Monday 9 a.m. - 6 p.m. KLM 102
Tuesday 9 a.m. - 6 p.m. KLM 102
Wednesday 9 a.m. - 6 p.m. KLM 102
Thursday 9 a.m. - 6 p.m. KLM 102
Friday 9 a.m. - 6 p.m. KLM 102

Rapid ANTIGEN Testing (Available ONLY to TAMIU Community)

  • Walk-up opportunity; no appointment needed

  • Scan posted QR code at the testing site on your smartphone
  • You’ll be linked to an authentication page; enter your valid TAMIU NetID and password
  • A DUO prompt and confirmation will follow
  • A simple online form follows and you’ll provide your email, phone, and University ID.  Please make sure these are accurately entered
  • Upon testing completion and results entry, an email will be sent to you with your results in approximately 30 minutes
  • Rapid Antigen Testing is open to all TAMIU students, faculty, staff and retirees

For more information, please contact The Office of Community Relations and Special Events at 956.326.2001


COVID-19 vaccines

You may reach out to one of our community partners for your vaccination needs. 

City of Laredo Health Department

2600 Cedar

956-795-4906

https://www.cityoflaredo.com/health/healthindex.htm

 

Gateway Community Health Center

1515 Pappas Street

956-795-8100

https://gatewaychc.com/

 

H-E-B Pharmacy

https://vaccine.heb.com/

 

  • MODERNA (18 years or older), JANSSEN (16 years or older) and PFIZER (12 years or older) 1st, 2nd, 3rd and booster doses approved
  • Booster doses are approved: MODERNA (18 years or older) and PFIZER (12 years or older)
  • Pediatric PFIZER doses are approved for children ages 5-11 years old
  • Mix and match doses are approved by the CDC
  • SECOND BOOSTER (MODERNA and PFIZER) is now approved for those who are eligible 
  • If you received Pfizer or Moderna primary series plus a first booster at least 4 months ago, you may be eligible for a SECOND BOOSTER vaccine
  • Guidance limits those eligible to receive a second booster dose to the following:
    • Individuals 50+ who have had a first booster of any authorized or approved COVID-19 vaccine at least 4 months ago
    • Individuals 18 years and older may receive a second booster of the MODERNA vaccine if they received a primary series of MODERNA and a first booster at least 4 months ago and are moderately or severely immunocompromised
    • Individuals 12 years and older may receive a second booster of the PFIZER vaccine if they received a primary series of PFIZER and a first boost at least 4 months ago and are moderately or severely immunocompromised
  •  In select individuals who are moderate to severely immunocompromised the CDC recommends a 3rd dose mRNA vaccine 28 days after their 2nd dose of a mRNA vaccine. They suggest using the same mRNA vaccine as previous but if unable to give the same vaccine as previous you can give the alternative mRNA vaccine
  • Moderate to severe immunodeficiencies are classified by the CDC as the following: 
    • Been receiving active cancer treatment for tumors or cancers of the blood
    • Received an organ transplant and currently taking medicine to suppress the immune system
    • Received a stem cell transplant within the last 2 years or currently taking medicine to suppress the immune system
    • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
    • Advanced or untreated HIV infection
    • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response